Connect with us

Health

Exports of medicinal and pharma products up by 13.5%

SHARE:

Published

1 year ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

In 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching €313.4 billion. At the same time, imports only recorded a modest increase of 0.5%, amounting to €119.7bn.

Consequently, in 2024, the EU's trade surplus in medicinal and pharmaceutical products came to a total of €193.6 billion, marking a record high.

Click to enlarge

Source dataset: ds-059331 

Top extra-EU exporters: Germany, Ireland and Belgium

In 2024, Germany was the EU’s largest extra-EU exporter of medicinal and pharmaceutical products (€67.9bn), followed by Ireland (€56.6bn) and Belgium (€41.4bn).

The largest extra-EU importers were Germany (€23bn), Belgium (€21.3bn) and the Netherlands (€14.7bn).

Main trade partners: US and Switzerland

The main destination for extra-EU exports of medicinal and pharmaceutical products in 2024 was the United States (38.2% of all exports outside the EU; €119.8bn), followed by Switzerland (16.4%; €51.3bn) and the United Kingdom (5.8%; €18.2bn).

Most of the imports to the EU came from the United States (38.3%; €45.9bn), Switzerland (32.6%; €39.1bn) and the United Kingdom (7.3%; €8.7bn).

Click to enlarge

Source dataset: ds-059331

For more information

Methodological notes

  • The Standard international trade classification (SITC) product code used for medicinal and pharmaceutical products is 54.
  • Dutch and Belgian trade flows are over-estimated because of the so-called ‘Rotterdam effect’ (or quasi-transit trade): goods originating in other EU countries that are exported through Dutch and Belgian ports are, according to EU rules, recorded as extra-EU exports by the Netherlands and Belgium. Similar considerations apply to imports from countries outside the EU that arrive in Dutch and Belgian ports and are re-exported to other EU countries.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending